ReThink Pharmaceuticals
Finding New Applications for Existing Drugs
Company Overview
Snapshot
Founded in December 2014 by Etty Amir, Ofer Tabach, Guy Seemann, and Dimitry Shvartsman, ReThink Pharmaceuticals operates with 1–10 employees. The company has secured $5K across one funding round. In December 2015, the company was highlighted for its approach to streamlining drug discovery.
Business overview
ReThink Pharmaceuticals is a computational biotech company specializing in drug repurposing. The company leverages a distinct algorithm based on evolutionary genomics (phylogenetic profiling) and innovative bioinformatics to discover new applications for existing drugs, drugs under clinical development, and shelved drugs that previously failed clinical trials. ReThink Pharmaceuticals aims to expand the connections between drugs and diseases, generating novel and accurate findings. It operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development, targeting the pharmaceutical industry, medical institutions, and rare disease foundations in markets like the United States.
Strategic signal
In December 2015, ReThink Pharmaceuticals was featured for its innovative approach to streamlining drug discovery, suggesting early validation of its computational biotech platform. This indicates the company's potential to significantly impact the pharmaceutical industry by accelerating the identification of new indications for existing drugs, thereby reducing development costs and timelines for investors and corporate innovation teams.
Log in to access full profile ›Company Intelligence Q&A
- When was ReThink Pharmaceuticals founded?
- ReThink Pharmaceuticals was founded in December 2014.
- Who are the founders of ReThink Pharmaceuticals?
- The co-founders of ReThink Pharmaceuticals are Etty Amir, Ofer Tabach, Guy Seemann, and Dimitry Shvartsman.
- What is ReThink Pharmaceuticals' primary focus?
- ReThink Pharmaceuticals is a computational biotech company focused on drug repurposing, using evolutionary genomics and bioinformatics to find new applications for existing drugs.
- What was a notable early recognition for ReThink Pharmaceuticals?
- In December 2015, ReThink Pharmaceuticals was recognized for its innovative approach to streamlining drug discovery, as reported by blogs.timesofisrael.com.
- What is the company's employee count?
- ReThink Pharmaceuticals has 1–10 employees.